Salman Khurshid dares Kejriwal to stage protest in Farrukhabad

Khurshid said that he has been made the Law Minister and asked to work with the pen and he will work with the pen but also with blood

New Delhi: Law Minister Salman Khurshid, in a clear challenge to Arvind Kejriwal, has dared him to stage a protest in his constituency Farrukhabad in Uttar Pradesh and said "let him also return from Farrukhabad", reports PTI.
At a closed-door function in New Delhi last night whose footage was aired by some news channels, Khurshid said, "I have been made the Law Minister and asked to work with the pen. I will work with the pen but also with blood."
Apparently referring to Kejriwal's threat to stage a protest in his home constituency from 1st November, the senior Congress leader said, "Let them come to Farrukhabad and visit Farrukhabad. But let him also return from Farrukhabad." 
Khurshid, whose NGO Zakir Hussain Memorial Trust has been accused by Kejriwal of financial bunglings, said, "They say we will ask questions and you have to give the answers. We say you hear the answers and forget about asking questions." 
Kejriwal saw the comments as a death threat to him. "Mr Salman Khurshid has threatened me. The kind of language which he has used, it does not suit the stature of country's Law Minister," the activist said.
"Killing me won't help because the country has been awakened. If one Arvind is killed, there will be another 100 Arvind. Rather than threatening like this, it would be better that Congress sensed the anger of people and took some concrete steps against corruption," he said.
Khurshid was accompanied by his wife Louise and several other supporters during the programme.



Dr Anantha K Ramdas

4 years ago

I have lost all my respect for Salman Kurshid as I always felt that he was a reasonable man and would listen patiently.

By challenging Arvind Kejriwal to come to his "territory" he is indirectly instigating the goonagiri attitude, which is not expected from the Law Minister of standing.

He has fallen down from the pedestal where most of us had placed him before.

Vinay Isloorkar

4 years ago


When yield point is crossed, irreversible plastic deformation starts. The "baagad bille" have started to crack. The jokers should be provoked into more displays of arrogance.


4 years ago

Congratulation Khurshids for your new NGO 'Zakir Hussain Memorial Blood Donor's Trust"



In Reply to MOHAN 4 years ago

It should be Blood Suckers Club.

Mahindra launches Rexton SUV at Rs17.67 lakh

Rexton, M&M's first high-end SUV from the the SsangYong stable is priced at Rs17.67 ex-Mumbai for manual version while automatic version is priced at Rs19.67 lakh

Mumbai: Mahindra & Mahindra (M&M), the country's largest utility vehicle maker on Wednesday launched a premium sports utility vehicle (SUV) 'Rexton' from the SsangYong stable, priced at Rs17.67 lakh, reports PTI.


The first launch from its Korean arm is produced at the Chakan plant with some localisation, the company said.


In November 2010, M&M had signed a definitive agreement with SsangYong Motor Company to acquire 70% stake in the ailing South Korean automaker at $463 million (about Rs2,105 crore).


"A manual model of the sports utility vehicle (SUV) is priced at Rs17.67 lakh ex-Mumbai and the automatic version at Rs19.67 lakh," M&M president, automotive and farm equipment, Pawan Goenka said at the launch.


The car is the first high-end SUV from the Mumbai-based auto company. The company said it has invested over Rs63 crore at its Chakan plant for this model.


Lupin gets US FDA nod for generic Avapro tablets

Irbesartan, the generic version of Sanofi Aventis's Avapro tablets is used in the treatment of hypertension and nephropathy in type II diabetic patients

Mumbai: Pharmaceutical company Lupin Ltd on Wednesday said its subsidiary, Lupin Pharmaceuticals, has received approval for its Irbesartan tablets from US Food and Drugs Administration (FDA) to market a generic version of Sanofi Aventis's Avapro tablets, reports PTI.
Irbesartan is used in the treatment of hypertension and nephropathy in type II diabetic patients, it added.
Irbesartan tablets are available from 75 to 300 mg and are the AB-rated generic equivalent of Sanofi Aventis's Avapro tablets, the company said in a statement issued here.
Avapro tablets had annual US sales of about $400.7 million in June, as per the IMS health sales data.
Lupin is the fifth largest generics player in the US with 5.1% market share by prescriptions.
The company said it is also the fastest growing top 10 pharmaceutical player in India, Japan and South Africa.


We are listening!

Solve the equation and enter in the Captcha field.

To continue

Sign Up or Sign In


To continue

Sign Up or Sign In



The Scam
24 Year Of The Scam: The Perennial Bestseller, reads like a Thriller!
Moneylife Magazine
Fiercely independent and pro-consumer information on personal finance
Stockletters in 3 Flavours
Outstanding research that beats mutual funds year after year
MAS: Complete Online Financial Advisory
(Includes Moneylife Magazine and Lion Stockletter)